Page 30 - Delivery Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Page Not Found | ZAWYA MENA Edition

Sublingual delivery is an emerging strategy for vaccines AUSTIN, Texas /Massachusetts Newswire – National News/ — Zeteo Biomedical, a privately held, biomedical device company, announced today it has been awarded a United States Patent for its “Oral Delivery Device and Methods” (US Patent 10238577). This latest patent expands the capabilities of Zeteo’s ZEOx1™ Delivery Platform to systemically deliver drugs or biologics, into the body non-invasively via the sublingual route. Sublingual delivery has emerged as a viable route of administration for vaccines and medications for pain,...

Sublingual delivery is an emerging strategy for vaccines

ENewsChannels NEWS: -- Zeteo Biomedical, a privately held, biomedical device company, announced today it has been awarded a United States Patent for its "Oral Delivery Device and Methods" (US Patent 10238577). This latest patent expands the capabilities of Zeteo's ZEO Delivery Platform to systemically deliver drugs or biologics, into the body non-invasively via the sublingual route. :: News from eNewsChannels

Researchers develop thermostable RNA vaccine delivery platform With the emergence of new and more infectious variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the induction of population immunity by mass vaccination appears to be the only definitive way to return to a ‘normal’ way of life. While some SARS-CoV-2 vaccines are already being distributed to millions of people under emergency use authorization, issues of stability and cost require the development of others. A new bioRxiv* preprint describes the production of a new RNA vaccine delivery system that pr...